Self-management of oral anticoagulant therapy: a systematic review and meta-analysis

Research output: Contribution to journalReviewResearchpeer-review

Standard

Self-management of oral anticoagulant therapy : a systematic review and meta-analysis. / Christensen, Thomas D; Johnsen, Søren P; Hjortdal, Vibeke E; Hasenkam, J Michael.

In: International Journal of Cardiology, Vol. 118, No. 1, 16.05.2007, p. 54-61.

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Christensen, TD, Johnsen, SP, Hjortdal, VE & Hasenkam, JM 2007, 'Self-management of oral anticoagulant therapy: a systematic review and meta-analysis', International Journal of Cardiology, vol. 118, no. 1, pp. 54-61. https://doi.org/10.1016/j.ijcard.2006.06.018

APA

Christensen, T. D., Johnsen, S. P., Hjortdal, V. E., & Hasenkam, J. M. (2007). Self-management of oral anticoagulant therapy: a systematic review and meta-analysis. International Journal of Cardiology, 118(1), 54-61. https://doi.org/10.1016/j.ijcard.2006.06.018

Vancouver

Christensen TD, Johnsen SP, Hjortdal VE, Hasenkam JM. Self-management of oral anticoagulant therapy: a systematic review and meta-analysis. International Journal of Cardiology. 2007 May 16;118(1):54-61. https://doi.org/10.1016/j.ijcard.2006.06.018

Author

Christensen, Thomas D ; Johnsen, Søren P ; Hjortdal, Vibeke E ; Hasenkam, J Michael. / Self-management of oral anticoagulant therapy : a systematic review and meta-analysis. In: International Journal of Cardiology. 2007 ; Vol. 118, No. 1. pp. 54-61.

Bibtex

@article{183d6a037a4e4a2da81814b1d8cd932b,
title = "Self-management of oral anticoagulant therapy: a systematic review and meta-analysis",
abstract = "BACKGROUND: A number of randomized controlled trials have compared self-management of oral anticoagulant therapy with conventional management. However, the results have not appeared consistent and a systematic review and meta-analysis are therefore needed in order to evaluate self-management of oral anticoagulant therapy. The aim of this study was to evaluate the efficacy and safety of self-management of oral anticoagulant therapy for patients on long-term oral anticoagulant therapy.METHODS: A systematic review and meta-analysis including randomized controlled trials with highly selected patients comparing self-management of oral anticoagulant therapy with conventional treatment. Data were extracted in terms of study characteristics, quality of trials and outcome (death, minor and major complications (thromboembolic and bleeding events), and time within therapeutic INR target range).RESULTS: Ten trials with a total of 2724 patients were included. Two of the trials could be classified as high quality trials. Considering all trials, self-management was associated with a reduced risk of death (relative risk (RR)=0.48, 95% confidence interval (CI) 0.29-0.79, p=0.004), major complications (RR=0.58, 95% CI 0.42-0.81, p=0.001) and with increasing time within therapeutic INR target range (weighted mean difference=6.53, 95% CI 2.24-10.82, p=0.003). No clear effect was found regarding minor complications (RR=0.98, 95% CI 0.49-1.99, p=0.96).CONCLUSIONS: A majority of the existing trials have various methodological problems. However, self-management of oral anticoagulant therapy appeared at least as good and possible better than conventional management in highly selected patients.",
keywords = "Administration, Oral, Anticoagulants/administration & dosage, Humans, International Normalized Ratio, Models, Statistical, Randomized Controlled Trials as Topic, Self Administration/statistics & numerical data, Thromboembolism/prevention & control",
author = "Christensen, {Thomas D} and Johnsen, {S{\o}ren P} and Hjortdal, {Vibeke E} and Hasenkam, {J Michael}",
year = "2007",
month = may,
day = "16",
doi = "10.1016/j.ijcard.2006.06.018",
language = "English",
volume = "118",
pages = "54--61",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

RIS

TY - JOUR

T1 - Self-management of oral anticoagulant therapy

T2 - a systematic review and meta-analysis

AU - Christensen, Thomas D

AU - Johnsen, Søren P

AU - Hjortdal, Vibeke E

AU - Hasenkam, J Michael

PY - 2007/5/16

Y1 - 2007/5/16

N2 - BACKGROUND: A number of randomized controlled trials have compared self-management of oral anticoagulant therapy with conventional management. However, the results have not appeared consistent and a systematic review and meta-analysis are therefore needed in order to evaluate self-management of oral anticoagulant therapy. The aim of this study was to evaluate the efficacy and safety of self-management of oral anticoagulant therapy for patients on long-term oral anticoagulant therapy.METHODS: A systematic review and meta-analysis including randomized controlled trials with highly selected patients comparing self-management of oral anticoagulant therapy with conventional treatment. Data were extracted in terms of study characteristics, quality of trials and outcome (death, minor and major complications (thromboembolic and bleeding events), and time within therapeutic INR target range).RESULTS: Ten trials with a total of 2724 patients were included. Two of the trials could be classified as high quality trials. Considering all trials, self-management was associated with a reduced risk of death (relative risk (RR)=0.48, 95% confidence interval (CI) 0.29-0.79, p=0.004), major complications (RR=0.58, 95% CI 0.42-0.81, p=0.001) and with increasing time within therapeutic INR target range (weighted mean difference=6.53, 95% CI 2.24-10.82, p=0.003). No clear effect was found regarding minor complications (RR=0.98, 95% CI 0.49-1.99, p=0.96).CONCLUSIONS: A majority of the existing trials have various methodological problems. However, self-management of oral anticoagulant therapy appeared at least as good and possible better than conventional management in highly selected patients.

AB - BACKGROUND: A number of randomized controlled trials have compared self-management of oral anticoagulant therapy with conventional management. However, the results have not appeared consistent and a systematic review and meta-analysis are therefore needed in order to evaluate self-management of oral anticoagulant therapy. The aim of this study was to evaluate the efficacy and safety of self-management of oral anticoagulant therapy for patients on long-term oral anticoagulant therapy.METHODS: A systematic review and meta-analysis including randomized controlled trials with highly selected patients comparing self-management of oral anticoagulant therapy with conventional treatment. Data were extracted in terms of study characteristics, quality of trials and outcome (death, minor and major complications (thromboembolic and bleeding events), and time within therapeutic INR target range).RESULTS: Ten trials with a total of 2724 patients were included. Two of the trials could be classified as high quality trials. Considering all trials, self-management was associated with a reduced risk of death (relative risk (RR)=0.48, 95% confidence interval (CI) 0.29-0.79, p=0.004), major complications (RR=0.58, 95% CI 0.42-0.81, p=0.001) and with increasing time within therapeutic INR target range (weighted mean difference=6.53, 95% CI 2.24-10.82, p=0.003). No clear effect was found regarding minor complications (RR=0.98, 95% CI 0.49-1.99, p=0.96).CONCLUSIONS: A majority of the existing trials have various methodological problems. However, self-management of oral anticoagulant therapy appeared at least as good and possible better than conventional management in highly selected patients.

KW - Administration, Oral

KW - Anticoagulants/administration & dosage

KW - Humans

KW - International Normalized Ratio

KW - Models, Statistical

KW - Randomized Controlled Trials as Topic

KW - Self Administration/statistics & numerical data

KW - Thromboembolism/prevention & control

U2 - 10.1016/j.ijcard.2006.06.018

DO - 10.1016/j.ijcard.2006.06.018

M3 - Review

C2 - 16891008

VL - 118

SP - 54

EP - 61

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

IS - 1

ER -

ID: 242781008